In the TME, tumor cells exploit cell exhaustion and cellular inactivation processes by expressing PD-L1 and PD-L2 themselves and inducing PD-1 on cytotoxic T-cells and PD-L1/PD-L2 on APCs (19). The gene discussed is CD274; the disease is neoplasm.